{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:09:26Z","timestamp":1783789766718,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bbrep.2021.101007","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:50:20Z","timestamp":1620157820000},"page":"101007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"van Santen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Out","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Zoutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.D.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Tensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bbrep.2021.101007_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbrep.2021.101007_bib2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-4632.2011.05188.x","article-title":"Prevalence and severity of pruritus in cutaneous T cell lymphoma","volume":"51","author":"Vij","year":"2012","journal-title":"Int. J. Dermatol."},{"issue":"7","key":"10.1016\/j.bbrep.2021.101007_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101007_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101007_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0625.2012.01487.x","article-title":"Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin","volume":"21","author":"Szegedi","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101007_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","article-title":"Correlation of IL-31 serum levels with severity of atopic dermatitis","volume":"122","author":"Raap","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrep.2021.101007_bib7","first-page":"1","article-title":"Interleukin-31 pathway and its role in atopic dermatitis: a systematic review","author":"Saleem","year":"2017","journal-title":"J. Dermatol. Treat."},{"issue":"3","key":"10.1016\/j.bbrep.2021.101007_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2340\/00015555-1345","article-title":"Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma","volume":"92","author":"Ohmatsu","year":"2012","journal-title":"Acta Derm. Venereol."},{"issue":"12","key":"10.1016\/j.bbrep.2021.101007_bib9","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/jid.2013.227","article-title":"IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus","volume":"133","author":"Singer","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.bbrep.2021.101007_bib10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2340\/00015555-2417","article-title":"Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin","volume":"96","author":"Nattkemper","year":"2016","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.bbrep.2021.101007_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2340\/00015555-1958","article-title":"Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease","volume":"95","author":"Malek","year":"2015","journal-title":"Acta Derm. Venereol."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101007_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00403-014-1527-x","article-title":"Analysis of the IL-31 pathway in Mycosis fungoides and Sezary syndrome","volume":"307","author":"Mobs","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"9","key":"10.1016\/j.bbrep.2021.101007_bib13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-Interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101007_bib14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbrep.2021.101007_bib15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2012.117","article-title":"A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides","volume":"132","author":"van Kester","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.bbrep.2021.101007_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.bbrep.2021.101007_bib17","first-page":"508","article-title":"Navigating the treatment choices for mycosis fungoides","volume":"24","author":"Lansigan","year":"2010","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.bbrep.2021.101007_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"van Doorn","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.bbrep.2021.101007_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5021\/ad.2011.23.4.468","article-title":"IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis","volume":"23","author":"Kim","year":"2011","journal-title":"Ann. Dermatol."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101007_bib20","first-page":"325","article-title":"Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum","volume":"11","author":"Martins","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.bbrep.2021.101007_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/all.12316","article-title":"Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge","volume":"69","author":"Hawro","year":"2014","journal-title":"Allergy"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:52:05Z","timestamp":1762501925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580821001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":21,"alternative-id":["S2405580821001011"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101007","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101007"}}